We built Zymergen to make revolutionary high-performance products that outshine existing materials while dramatically reducing environmental impacts from manufacturing, transportation and more. This is the right investment for this moment, advancing our transformational long-term vision and bringing real products to market.
Zymergen, one of the companies that’s developing biomanufacturing technologies that could reshape any number of industries, said it has raised $300 million in financing. It’s part of a wave of biotech companies that TechCrunch covered in depth last month. Synthetic biology startups are …